Gastrointestinal Dysfunction Criteria in Critically Ill Children: The PODIUM Consensus Conference

Katri V Typpo1, Sharon Y Irving2, Jose M Prince3

  • 1Department of Pediatrics and the Steele Children's Research Center, University of Arizona College of Medicine, Tucson, Arizona.

Pediatrics
|December 31, 2021
PubMed

Insights

New criteria for severe gastrointestinal dysfunction in critically ill children were developed. These criteria include specific findings like bowel perforation or ischemia, aiding in the understanding of pediatric multiple organ dysfunction syndrome (MODS).

Area of Science:

  • Pediatric critical care medicine
  • Gastroenterology
  • Diagnostic criteria development

Background:

  • Existing criteria for pediatric multiple organ dysfunction syndrome (MODS) lack specific inclusion of gastrointestinal dysfunction.
  • Gastrointestinal dysfunction plays a significant role in the pathophysiology and outcomes of pediatric critical illness.

Purpose of the Study:

  • To evaluate existing evidence on gastrointestinal dysfunction in critically ill children.
  • To develop consensus criteria for identifying severe gastrointestinal dysfunction in this population.

Main Methods:

  • A systematic electronic literature search of PubMed and EMBASE (1992-2020) was performed.
  • Inclusion criteria focused on critically ill children with gastrointestinal dysfunction and relevant outcome assessments.
  • Exclusion criteria removed studies on adults, premature infants, animal models, and non-English literature.

Main Results:

  • Severe gastrointestinal dysfunction criteria include: 1a) bowel perforation, 1b) pneumatosis intestinalis, or 1c) bowel ischemia, confirmed by imaging or surgical inspection.
  • Alternatively, rectal sloughing of gut mucosa is also indicative of severe gastrointestinal dysfunction.
  • These criteria were derived from a systematic review of eligible studies.

Conclusions:

  • The developed consensus criteria provide a framework for defining severe gastrointestinal dysfunction in critically ill children.
  • Further research is needed to enhance the validity of these criteria due to current evidence limitations.
  • Accurate identification of gastrointestinal dysfunction is crucial for understanding and managing pediatric MODS.
Abstract

Related Concept Videos

Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
651
Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
326
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
14
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
449
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
375
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
448